Transplant doctors clash over Chinese organ donor system


Criticism of alleged forced organ harvesting in China reached fever pitch this week as the 26th International Congress of The Transplantation Society convened for the first time on Chinese soil.

The Congress, which opened in Hong Kong on Wednesday, features a number of presentations from Chinese researchers, including former Vice-Minister for Health Huang Jiefu, and marks the end of a longstanding Transplantation Society (TTS) embargo on research from China.

Despite claims from Chinese officials that organs will no longer be harvested from executed prisoners, experts from around the world have slammed TTS for this year’s Congress, saying it implies implicit endorsement of current and past organ harvesting practices in China.

In an article published on Wednesday in the American Journal of Transplantation, a day before the Congress opened in Hong Kong, doctors and members of a non-governmental medical organization questioned the “veracity of the announced changes”:

“It is noticeable that China has neither addressed nor included in the reform a pledge to end the procurement of organs from prisoners of conscience, nor have they initiated any legislative amendments...Until we have independent and objective evidence of a complete cessation of unethical organ procurement from prisoners, the medical community has a professional responsibility to maintain the academic embargo on Chinese transplant professionals.”

Current TTS president Philip O’Connell and past president Jeremy Chapman, both Australian doctors based in Sydney, have been heavily criticised for ongoing collaboration with researchers from Chinese hospitals.

Despite having expressed grave concerns about China’s practices as late as December 2013, Jeremy Chapman told the Sydney Morning Herald earlier this year that he believes China has ended the use of organs from executed prisoners. 




MORE ON THESE TOPICS | china, falun gong, forced organ harvesting, organ transplantation

This article is published by Xavier Symons and BioEdge under a Creative Commons licence. You may republish it or translate it free of charge with attribution for non-commercial purposes following these guidelines. If you teach at a university we ask that your department make a donation. Commercial media must contact us for permission and fees. Some articles on this site are published under different terms.

 
 Search BioEdge

 Subscribe to BioEdge newsletter
rss Subscribe to BioEdge RSS feed


 Best of the web
 
comments powered by Disqus